Peptide profile
Tetrapeptide-68 (Adifyline)
Tetrapeptide for facial fat restoration
Compare Tetrapeptide-68 (Adifyline) with other peptides →Summary
A peptide that helps make new fat cells to fill out your face.
- Typical dose
- 2-5% for topical / 1-5mg per area injectable 1x daily (topical) or every 2-3 weeks (injectable)
- Route
- Topical
- Cycle length
- 3-4 months
- Evidence
- Animal data
Mechanism
How it works
Adifyline works like a fat cell recruiter — it tells stem cells in your skin to become plump, volume-restoring fat cells instead of staying dormant.
Tetrapeptide-68 is a synthetic adipogenesis peptide that differentiates pre-adipocytes into mature fat cells and increases lipid accumulation.
Reported in research
Benefits
- Helps your body make new fat cells
- Brings back lost fullness in your face
- Plumps up saggy skin
- Fills in hollow spots under eyes and cheeks
Context, not a prescription
Dosing
- Typical range
- 2-5% for topical / 1-5mg per area injectable 1x daily (topical) or every 2-3 weeks (injectable) (Topical)
- Cycle length
- 3-4 months
Safety
Side effects & contraindications
Possible side effects
- Mild topical redness
- Injectable: temporary swelling
- Injectable: lumps or unevenness
- Contact dermatitis
Contraindications
- Pregnancy or breastfeeding
- Active skin infection
- History of lipodystrophy disorders
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Your face looks fuller. Hollow spots fill in. Skin is plumper and wrinkles look softer.
How it works
Adifyline is like a coach for fat cells. It tells sleepy stem cells in your skin to wake up and become plump fat cells.
It turns on special switches inside baby fat cells. This makes them grow and store fat.
What to expect
You can see plumping in 2-3 months (on skin) or 1-2 months (shot).
- Weeks 2-4: Your skin gets a little thicker (when put on the skin).
- Weeks 6-8: You can see hollow spots filling in.
- Weeks 10-12: Your face looks its fullest.
Good to know
- Try the skin version before the shot
- Test a small spot first
Staying safe
- A little redness on the skin
- Shot: swelling for a short time
Avoid if you have:
- If you are pregnant or breastfeeding
- If you have a skin infection right now
- If you have had problems with how your body stores fat
Mechanism of action
Tetrapeptide-68 is a synthetic adipogenesis peptide that differentiates pre-adipocytes into mature fat cells and increases lipid accumulation.
Activates PPAR-γ and C/EBP-α pathways in adipose precursor cells, promoting proliferation and lipid storage.
Pharmacodynamics
Visible plumping at 2-3 months (topical) or 1-2 months (injectable).
Increased facial volume, reduced hollows, plumper skin, softer wrinkles.
Timeline
- Weeks 2-4: Subtle increased skin thickness (topical).
- Weeks 6-8: Visible plumping of hollows.
- Weeks 10-12: Maximum volume restoration.
Comparisons
- Adifyline — effectiveness Emerging, safety Good, cost $$$, Medium to use
- Hyaluronic Acid Filler — effectiveness High, safety Good, cost $$$$, Hard to use
Adverse effects
Common:
- Mild topical redness
- Injectable: temporary swelling
Rare:
- Injectable: lumps or unevenness
- Contact dermatitis
Contraindications & risk mitigation
Contraindicated in:
- Pregnancy or breastfeeding
- Active skin infection
- History of lipodystrophy disorders
- Start with topical before injectable
- Small test area first
Qué hace
Tu rostro se ve más lleno. Los huecos se rellenan. La piel está más firme y las arrugas se ven más suaves.
Cómo funciona
Adifyline es como un entrenador para las células grasas. Le dice a las células madre adormecidas de tu piel que despierten y se conviertan en células grasas rellenas.
Enciende interruptores especiales dentro de las células grasas inmaduras. Esto hace que crezcan y almacenen grasa.
Qué esperar
Puedes ver el relleno en 2-3 meses (en la piel) o 1-2 meses (inyección).
- Semanas 2-4: Tu piel se vuelve un poco más gruesa (al aplicarla en la piel).
- Semanas 6-8: Puedes ver cómo se rellenan los huecos.
- Semanas 10-12: Tu rostro se ve en su punto de mayor volumen.
Bueno saber
- Prueba la versión para la piel antes de la inyección
- Prueba primero en una pequeña zona
Manteniéndose seguro
- Un poco de enrojecimiento en la piel
- Inyección: hinchazón por un corto tiempo
Evitar si tienes:
- Si estás embarazada o en periodo de lactancia
- Si tienes una infección en la piel en este momento
- Si has tenido problemas con la forma en que tu cuerpo almacena grasa
Mecanismo de acción
El Tetrapéptido-68 es un péptido adipogénico sintético que diferencia los preadipocitos en células grasas maduras y aumenta la acumulación de lípidos.
Activa las vías PPAR-γ y C/EBP-α en células precursoras adiposas, promoviendo la proliferación y el almacenamiento de lípidos.
Farmacodinamia
Relleno visible a las 2-3 meses (tópico) o 1-2 meses (inyectable).
Aumento del volumen facial, reducción de huecos, piel más rellena, arrugas más suaves.
Cronología
- Semanas 2-4: Aumento sutil del grosor de la piel (tópico).
- Semanas 6-8: Relleno visible de los huecos.
- Semanas 10-12: Restauración máxima del volumen.
Comparaciones
- Adifyline — efectividad Emergente, seguridad Buena, costo $$$, Media de usar
- Relleno de ácido hialurónico — efectividad Alta, seguridad Buena, costo $$$$, Difícil de usar
Efectos adversos
Comunes:
- Enrojecimiento tópico leve
- Inyectable: hinchazón temporal
Raros:
- Inyectable: bultos o irregularidades
- Dermatitis de contacto
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Embarazo o lactancia
- Infección cutánea activa
- Antecedentes de trastornos de la lipodistrofia
- Comience con la versión tópica antes de la inyectable
- Pruebe primero en un área pequeña
Reference data
Specifications
- Route
- Topical
- Cycle length
- 3-4 months
FAQ
Common questions
Does it cause irregular lumps?
Injectable version requires skilled application; lash effects are rare but possible.
Is topical effective?
Less potent than injectable but still increases skin thickness with prolonged use.
What is the evidence level?
This compound is classified as Animal data. Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Research
Research & sources
Current evidence for Tetrapeptide-68 (Adifyline) is rated as Animal data. Research is based primarily on animal models.
- 1. Adifyline facial volume (2018) — DOI:10.1111/jocd.12562
- 2. Peptide adipogenesis (2020) — DOI:10.1111/jocd.13428
- 3. Adifyline facial volume (2018)
- 4. Peptide adipogenesis (2020)